Tenax Therapeutics, Inc.
TENX
$1.83
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 17.88% | -14.81% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 13.34% | 0.75% | |||
| Operating Income | -13.34% | -0.75% | |||
| Income Before Tax | -13.28% | -1.13% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -13.28% | -1.13% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -13.28% | -1.13% | |||
| EBIT | -13.34% | -0.75% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -0.72% | 8.50% | |||
| Normalized Basic EPS | -0.69% | 8.51% | |||
| EPS Diluted | -0.72% | 8.50% | |||
| Normalized Diluted EPS | -0.69% | 8.51% | |||
| Average Basic Shares Outstanding | 12.48% | 10.53% | |||
| Average Diluted Shares Outstanding | 12.48% | 10.53% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||